Results 231 to 240 of about 158,092 (291)

Jieduquyuziyin prescription for systemic lupus erythematosus: a system-level therapeutic strategy for immunological recalibration. [PDF]

Chin Med
Gan Y, Liu J, Zhou S, Lin K, Wang X, Fan Y, Xu L, Bao J.   +7 more
europepmc   +1 more source

The Diagnostic Value of Cellular Phenotyping and Pathological Casts Using Urine Flow Cytometry in Children with Lupus Nephritis. [PDF]

Diseases
Marpaung FR, Prasetyo RV, Lumban Toruan AA, Santoso D, Aryati A.   +4 more
europepmc   +1 more source

GBP2 promotes podocyte pyroptosis and contributes to the pathogenesis of pediatric lupus nephritis. [PDF]

PLoS One
Sun Y, Wei J, Zhao Y, Jiang X, He C, Huang X, Lei F, Qin Y.   +7 more
europepmc   +1 more source

The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomization. [PDF]

Front Immunol
Nagra D, Zuckerman B, Odia J, Patel S, Ong M, Adas M, Yang Z, Bechman K, Russell M, Bhandari S, Rosa C, Banerjee S, Blake T, Gullick N, Kasavkar G, Wincup C.   +15 more
europepmc   +1 more source

Effectiveness of IV cyclophosphamide and mycophenolate mofetil in the treatment of childhood-onset lupus nephritis in a resource-limited setting. [PDF]

BMC Rheumatol
Guiang-Valerio AKM, Collante MTM, Bernal CB.   +2 more
europepmc   +1 more source

Response to the Letter to the Editor Entitled "Beyond Lymphocytic Inflammation: Immune Architecture as a Determinant of Renal Outcomes". [PDF]

Kidney Int Rep
Boudhabhay I, Isnard P.
europepmc   +1 more source

PHLDB1 and WDFY4 as dual-state biomarkers in SLE pathogenesis and lupus nephritis prediction. [PDF]

BMC Immunol
Zhai J, Zhang L, Jia W, Pan Y, Zhang P, Zou Q, Wu Y.   +6 more
europepmc   +1 more source

Serum and urinary soluble CD163 in children with active lupus nephritis. [PDF]

Pediatr Rheumatol Online J
Owaidy RHE, Ibraheem MA, Alkhateeb YH, Taha AA, Taha SI, Sallam DE.   +5 more
europepmc   +1 more source